- Home
- MSM vs OGN Comparison
MSM vs OGN Comparison
Compare MSM & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- OGN
- Stock Information
- Founded
- MSM 1941
- OGN 1923
- Country
- MSM United States
- OGN United States
- Employees
- MSM N/A
- OGN N/A
- Industry
- MSM Industrial Machinery/Components
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- MSM Industrials
- OGN Health Care
- Exchange
- MSM Nasdaq
- OGN Nasdaq
- Market Cap
- MSM 4.7B
- OGN 2.5B
- IPO Year
- MSM 1995
- OGN N/A
- Fundamental
- Price
- MSM $90.18
- OGN $9.82
- Analyst Decision
- MSM Hold
- OGN Hold
- Analyst Count
- MSM 5
- OGN 4
- Target Price
- MSM $90.60
- OGN $18.00
- AVG Volume (30 Days)
- MSM 826.8K
- OGN 3.5M
- Earning Date
- MSM 07-01-2025
- OGN 08-05-2025
- Dividend Yield
- MSM 3.79%
- OGN 0.81%
- EPS Growth
- MSM N/A
- OGN N/A
- EPS
- MSM 3.54
- OGN 2.88
- Revenue
- MSM $3,743,630,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- MSM N/A
- OGN N/A
- Revenue Next Year
- MSM $4.26
- OGN $1.11
- P/E Ratio
- MSM $25.33
- OGN $3.42
- Revenue Growth
- MSM N/A
- OGN N/A
- 52 Week Low
- MSM $68.10
- OGN $8.01
- 52 Week High
- MSM $92.68
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- MSM 66.30
- OGN 48.62
- Support Level
- MSM $89.14
- OGN $9.74
- Resistance Level
- MSM $92.68
- OGN $10.27
- Average True Range (ATR)
- MSM 2.21
- OGN 0.36
- MACD
- MSM 0.33
- OGN -0.00
- Stochastic Oscillator
- MSM 77.95
- OGN 29.78
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.